We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026

Flow Cytometer for in Vitro Diagnostics

By HospiMedica staff writers
Posted on 30 Sep 2004
A new flow cytometer, designed for in vitro diagnostic (IVD) use, can assist clinical laboratories to obtain quality data quickly and efficiently, with processing speeds of up to 10,000 events per second.

Called the FACSCanto system, the new benchtop analyzer supports the routine and complex tests performed in clinical laboratories as well as clinical research and life science applications. More...
The system offers high fluorescence sensitivity, minimal sample contamination, and facilitates rare-event analysis, an important feature for clinical diagnostic laboratories. FACSCanto was developed by Becton Dickinson and Company (BD, San Jose, CA, USA).

The system's fixed optical alignment means that users are not required to manually align lasers, and the fluidics cart holds all fluids necessary for routine operation and maintenance. The self-contained design facilitates automated cleaning, startup, and shutdown routines, allowing laboratorians to concentrate on analysis and reporting of data.

"We leveraged our 30-plus years of expertise in flow cytometry in the design of the BD FACSCanto system,” noted Bill Rhodes, vice president and general manager, BD Biosciences Immunocytometry Systems. "It incorporates many technology advances first developed in our BD LSR II expandable cell analyzer and our BD FACSAria cell sorter, and we are proud to deliver such an advanced, yet easy-to-use, system to the clinical diagnostics market.”




Related Links:
BD

Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Pipette Calibration System
Artel PCS®
New
Automated Coagulation Analyzer
Hemolumi H6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.